Stop the rot!
OPINION: Bayer Crop Science closing its Hastings research site could be the tip of the iceberg.
A new ready-to-use antibiotic formulation for treating mastitis is now available for New Zealand dairy farmers.
Penethaject RTU (ready to use) took seven years to develop, register and launch; it has a unique formulation that requires no pre-mixing.
It’s the first time such a formulation has been developed anywhere in the world.
Bayer dairy veterinarian Dr Ray Castle says Penethaject RTU will make it easier for farmers to effectively treat clinical mastitis, a condition affecting 10-20% of NZ’s five million dairy cows every year.
“The active ingredient of Penethaject RTU, known as Penethamate, previously came in powder form and had to be mixed with a liquid by the farmer or veterinarian to create an injectable solution.
“Developing a pre-formulated version had been a scientific challenge for many years until scientists in Bayer NZ’s laboratories worked with Otago University to create a stable formulation, something that had never been achieved before.”
Castle says Penethamate is stable long term as a powder but not as a liquid.
“The challenge was to create a liquid formulation in which the active ingredient remained stable and active without caking or sticking together in clumps.”
To overcome the caking issue, Bayer worked with Otago University on adding different ingredients to stabilise the formulation, before finding a formulation that worked.
“The whole process, including clinical trials, stability testing, registration and commercial manufacturing, took about seven years. It’s a world-first and confirms NZ’s position as a leader in dairy science.”
Castle says the chemistry in Penethaject, a form of penicillin injected into the cow’s muscle, is so ‘clever’ that it allows antibiotic concentrations to build up in a cow’s udder. These concentrations are up to 10 times higher than those achieved by other penicillin formulations.
This allows the antibiotic to directly work on the mastitis bacteria, particularly Streptococcus uberis, the most common bacteria responsible for mastitis in NZ.
Once the mastitis is treated, the antibiotic quickly leaves the milk, allowing the cow to be back in milk production, in some cases within 48 hours.
Castle says farmers need to be particularly alert to the clinical signs of mastitis, which include changes in the colour and consistency of the milk, and/or redness, heat and swelling in the udder.
Penethaject RTU is a restricted veterinary medicine, and is only available under veterinary authorisation.
Another Australian state has given the green light to virtual fencing, opening another market for Kiwi company Halter.
Farmer interest continues to grow as a Massey University research project to determine the benefits or otherwise of the self-shedding Wiltshire sheep is underway. The project is five years in and has two more years to go. It was done mainly in the light of low wool prices and the cost of shearing. Peter Burke recently went along to the annual field day held Massey's Riverside farm in the Wairarapa.
Applications are now open for the 2026 NZI Rural Women Business Awards, set to be held at Parliament on 23 July.
Ravensdown has announced a collaboration with Kiwi icon, Footrot Flats in an effort to bring humour, heart, and connection to the forefront of the farming sector.
Forest & Bird's Kiwi Conservation Club is inviting New Zealanders of all ages to embrace the outdoors with its Summer Adventure Challenges.
Fonterra has slashed another 50c off its milk price forecast as global milk flows shows no sign of easing.